CMOPF
Cosmo N.V.
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
72.04
▼ 0.96 (1.32%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
73.00
Day high
72.40
Day low
72.40
Volume
256
Market cap
—
P/E (TTM)
—
52W range
69.71 – 169.90
Trailing performance
Returnvs SPY
1W
-4.04%
-2.7%
1M
-13.65%
-17.4%
3M
-26.49%
-29.6%
6M
-54.42%
-65.5%
YTD
-45.83%
-58.1%
1Y
-3.95%
-23.9%
3Y
+43.22%
-30.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on CMOPF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $104.17M | $266.79M | $92.78M | $102.09M | -61.0% |
| Operating revenue | $104.17M | $266.79M | $92.78M | $102.09M | -61.0% |
| Cost of revenue | $53.62M | $45.36M | $19.09M | $18.76M | +18.2% |
| Gross profit | $50.56M | $221.43M | $73.69M | $83.33M | -77.2% |
| Research & development | $34.17M | $39.93M | $3.17M | — | -14.4% |
| Selling, general & admin | $63.00K | $6.00K | $5.33M | $3.55M | +950.0% |
| Total operating expense | $57.49M | $73.15M | $67.54M | $55.27M | -21.4% |
| Operating income | -$6.94M | $148.28M | $6.16M | $28.06M | -104.7% |
| Net interest income | $876.00K | $1.55M | -$4.58M | -$6.33M | -43.4% |
| Pre-tax income | -$918.00K | $153.37M | -$6.49M | $24.47M | -100.6% |
| Tax provision | $2.57M | $20.18M | $4.21M | $6.97M | -87.3% |
| Net income | -$3.61M | $133.24M | -$10.78M | $17.23M | -102.7% |
| Net income to common | -$3.61M | $133.24M | -$10.78M | $17.23M | -102.7% |
| Basic EPS | -0.23 | 8.15 | -0.67 | 1.05 | -102.8% |
| Diluted EPS | -0.23 | 8.12 | -0.67 | 1.05 | -102.8% |
| EBIT | -$798.00K | $153.42M | $2.04M | $33.63M | -100.5% |
| EBITDA | $11.96M | $165.71M | $13.89M | $47.49M | -92.8% |
| Basic shares | 15.97M | 16.36M | 16.11M | 16.43M | -2.4% |
| Diluted shares | 15.97M | 16.42M | 16.11M | 16.43M | -2.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $55.87M | $44.30M | $50.27M | $185.82M | +26.1% |
| Cash & short-term investments | $122.76M | $142.96M | $50.27M | $240.95M | -14.1% |
| Accounts receivable | $24.14M | $18.94M | $28.45M | $34.08M | +27.5% |
| Inventory | $10.43M | $13.51M | $14.20M | $11.50M | -22.8% |
| Total current assets | $183.28M | $202.26M | $102.23M | $306.10M | -9.4% |
| Property, plant & equipment | $30.81M | $29.09M | $28.59M | $30.28M | +5.9% |
| Goodwill & intangibles | $349.89M | $355.93M | $362.37M | $390.39M | -1.7% |
| Total assets | $612.64M | $646.77M | $526.04M | $759.59M | -5.3% |
| Total current liabilities | $25.52M | $48.27M | $25.11M | $194.95M | -47.1% |
| Current debt | $141.00K | $139.00K | $137.00K | $171.07M | +1.4% |
| Long-term debt | $143.00K | $282.00K | $422.00K | $559.00K | -49.3% |
| Total debt | $4.26M | $2.20M | $1.84M | $173.60M | +93.8% |
| Total liabilities | $123.46M | $141.68M | $122.42M | $295.80M | -12.9% |
| Retained earnings | $316.10M | $323.06M | $220.70M | $254.75M | -2.2% |
| Shareholder equity | $482.30M | $498.33M | $396.82M | $456.93M | -3.2% |
| Working capital | $157.76M | $153.99M | $77.11M | $111.15M | +2.4% |
| Net tangible assets | $132.41M | $142.40M | $34.45M | $66.53M | -7.0% |
| Shares issued | 17.54M | 17.54M | 17.54M | 17.54M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$918.00K | $153.37M | -$6.97M | $24.47M | -100.6% |
| Depreciation & amortisation | $12.76M | $12.29M | $11.85M | $13.86M | +3.8% |
| Stock-based compensation | $2.60M | $2.07M | $3.83M | $2.08M | +25.2% |
| Change in working capital | -$4.47M | $113.00K | $946.00K | -$13.31M | -4,055.8% |
| Operating cash flow | -$12.48M | $162.41M | $22.71M | $33.23M | -107.7% |
| Capital expenditure | -$5.46M | -$5.65M | -$4.40M | -$7.31M | +3.4% |
| Investing cash flow | $50.47M | -$128.88M | $53.22M | $1.69M | +139.2% |
| Share buybacks | -$7.92M | -$5.93M | -$12.47M | -$24.75M | -33.5% |
| Dividends paid | -$32.68M | -$32.09M | -$16.89M | -$15.61M | -1.8% |
| Financing cash flow | -$24.45M | -$40.22M | -$211.27M | -$46.13M | +39.2% |
| Free cash flow | -$17.95M | $156.76M | $18.31M | $25.92M | -111.4% |
| End cash position | $55.87M | $44.30M | $50.27M | $185.82M | +26.1% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $55.87M | $50.75M | $44.30M | +10.1% |
| Cash & short-term investments | $122.76M | $126.63M | $142.96M | -3.1% |
| Accounts receivable | $24.14M | $21.62M | $18.94M | +11.7% |
| Inventory | $10.43M | $12.38M | $13.51M | -15.8% |
| Total current assets | $183.28M | $187.23M | $202.26M | -2.1% |
| Property, plant & equipment | $30.81M | $29.77M | $29.09M | +3.5% |
| Goodwill & intangibles | $349.89M | $353.13M | $355.93M | -0.9% |
| Total assets | $612.64M | $610.33M | $646.77M | +0.4% |
| Total current liabilities | $25.52M | $48.72M | $48.27M | -47.6% |
| Current debt | $141.00K | $139.00K | $139.00K | +1.4% |
| Long-term debt | $143.00K | $284.00K | $282.00K | -49.6% |
| Total debt | $4.26M | $2.70M | $2.20M | +58.0% |
| Total liabilities | $123.46M | $143.35M | $141.68M | -13.9% |
| Retained earnings | $316.10M | $312.82M | $323.06M | +1.1% |
| Shareholder equity | $482.30M | $460.24M | $498.33M | +4.8% |
| Working capital | $157.76M | $138.51M | $153.99M | +13.9% |
| Net tangible assets | $132.41M | $107.11M | $142.40M | +23.6% |
| Shares issued | 17.54M | 17.54M | 17.54M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
74.26
-2.99% from price
SMA 20
74.68
-3.54% from price
SMA 50
79.12
-8.94% from price
SMA 100
92.27
-21.93% from price
SMA 200
107.80
-33.17% from price
EMA 12
73.97
-2.61% from price
EMA 26
75.93
-5.13% from price
EMA 50
80.50
-10.50% from price
RSI (14)
37.7
Neutral
MACD (12,26,9)
-1.96
Hist 0.05
ATR (14)
1.51
2.09% of price
Realised vol 30D
41.8%
Annualised
Bollinger upper
78.18
20, 2σ
Bollinger lower
71.19
20, 2σ
50 / 200 cross
Death
79.12 vs 107.80
Trend bias
Below 200
-33.17%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.46
Less volatile than market
Correlation to SPY
0.10
Largely independent
Realised vol 30D
41.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-57.2%
Peak to trough
Max drawdown 5Y
-57.2%
Peak to trough
ATR 14
1.51
2.09% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Cosmo Announces SIX Ticker Symbol Change to "CMHC"
TMX Newsfile · 10d ago
UPDATE: Phase 3 Data Support a Novel Mechanism for Male Hair Loss: Spokane Dermatologist Dr. Wm. Philip Werschler on the Significance of the Clascoterone Results
GlobeNewswire · 11d ago
Phase 3 Data Support a Novel Mechanism for Male Hair Loss: Spokane Dermatologist Dr. Wm. Philip Werschler on the Significance of the Clascoterone Results
GlobeNewswire · 13d ago
Cosmo (SWX:COPN) Reports Weaker Half Year Results, Is It Still A Bargain?
Simply Wall St. · 31d ago
Cosmo NV (CMOPF) Half Year 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
GuruFocus.com · 32d ago
Cosmo Reports Double-Digit Recurring Revenue Growth in H1 2026, Advances Clascoterone 5% Topical Solution Toward Regulatory Submission, and Confirms Full-Year Guidance
TMX Newsfile · 32d ago
Invitation to Cosmo's Half-Year 2026 Financial Results Webcast on 23 July 2026
TMX Newsfile · 54d ago
Cosmo Welcomes the Launches of Winlevi(R) in Austria and Germany
TMX Newsfile · 70d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.